The Innovative Medicines Fund is a proposed £340 million fund to give “quicker access to the most advanced, life-saving treatments”. It is an extension of the existing Cancer Drugs Fund (CDF), which has already improved access to promising new oncology treatments.
The IMF will expand coverage to other innovative medicines, including those for rare conditions and smaller patient populations.
Last modified: 20 September 2023
Last reviewed: 20 September 2023